Radiotherapy improves survival in early stage extranodal natural killer/T cell lymphoma patients receiving asparaginase-based chemotherapy

This study retrospectively investigated asparaginase-based chemotherapy treatment outcomes with or without radiotherapy in 143 patients with stage I(E)–II(E) extranodal natural killer/T cell lymphoma (ENKTCL). All patients received a median of three cycles of asparaginase-based chemotherapy, while 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yi-Yang, Feng, Ling-Ling, Niu, Shao-Qing, Wang, Han-Yu, Zhang, Lu-Lu, Wang, Liang, Xia, Zhong-Jun, Huang, Hui-Qiang, Xia, Yun-Fei, Zhang, Yu-Jing, Wang, Xi-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355279/
https://www.ncbi.nlm.nih.gov/pubmed/28002792
http://dx.doi.org/10.18632/oncotarget.14006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355279/
https://www.ncbi.nlm.nih.gov/pubmed/28002792
http://dx.doi.org/10.18632/oncotarget.14006

Ejemplares similares